YAP1 and neoplasm: Because there are standard treatment regimens applied when a patient receives a clinical/pathologic diagnosis of SCLC, it is of substantial importance to be sure of this diagnosis when lung tumors posing diagnostic problems such as a YAP1 expressing, neuroendocrine marker low expressing tumor are encountered.